Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 16Cancer Pain 14Neoplasms 13Agnosia 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuralgia 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma, Follicular 2Lymphoma 2Inflammation 2Head and Neck Neoplasms 2Bronchiolitis Obliterans Syndrome 2Acute Pain 2Waldenstrom Macroglobulinemia 1Urinary Tract Infections 1Trigger Finger Disorder 1Thrombocythemia, Essential 1Stomatitis 1Staphylococcal Infections 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Oxycodone × Clear all
NCT06041425 2024-02-28

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

The First Affiliated Hospital with Nanjing Medical University

Phase 4 Completed
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Inflammation, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡